8 Knots Management LLC Invests $22.86 Million in HCA Healthcare, Inc. $HCA

8 Knots Management LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) during the 3rd quarter, according to its most recent filing with the SEC. The firm bought 53,641 shares of the company’s stock, valued at approximately $22,862,000. HCA Healthcare accounts for 2.6% of 8 Knots Management LLC’s holdings, making the stock its 13th biggest position.

A number of other hedge funds also recently made changes to their positions in the company. Brighton Jones LLC acquired a new position in HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC lifted its position in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC increased its holdings in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares during the last quarter. Allworth Financial LP lifted its holdings in HCA Healthcare by 21.8% during the 2nd quarter. Allworth Financial LP now owns 972 shares of the company’s stock worth $372,000 after buying an additional 174 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in shares of HCA Healthcare by 5.8% in the 2nd quarter. PNC Financial Services Group Inc. now owns 40,506 shares of the company’s stock valued at $15,518,000 after acquiring an additional 2,217 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares in the company, valued at $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 15,214 shares of company stock valued at $7,797,595. 1.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on HCA. Wall Street Zen lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Royal Bank Of Canada boosted their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. TD Cowen raised their target price on shares of HCA Healthcare from $529.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, March 10th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $537.73.

Read Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Trading Up 0.2%

HCA stock opened at $533.39 on Friday. The firm has a 50-day moving average of $507.05 and a two-hundred day moving average of $470.03. The firm has a market capitalization of $119.28 billion, a PE ratio of 18.79, a P/E/G ratio of 1.64 and a beta of 1.34. HCA Healthcare, Inc. has a one year low of $313.21 and a one year high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is 10.15%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.